News

CSL Seqirus, a subsidiary of Australia’s CSL Limited, said it has commenced shipping its differentiated portfolio of ...
RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...
Shares of GSK rose on Thursday after the company announced it had begun shipping its seasonal flu vaccines, Fluarix and ...
Co-administration of OVX836 with seasonal inactivated influenza vaccine (Fluarix® Tetra) was well-tolerated and demonstrated a favorable safety profileRobust complementary immune responses were ...
Flu cases are on the rise this season, as vaccination levels fall and COVID-style social distancing falls by the wayside.
Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...
Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...
The Centers for Disease Control and Prevention ended its emergency response to bird flu as the outbreak that sickened dozens ...
The CDC is ending its emergency response to bird flu, citing a significant drop in cases between February and July.
That's because the flu can come with fever and chills, cough, sore throat, tiredness, headache, muscle aches and joint pain, ...
According to the CDC, there has been a decline in animal infections and no reports of human cases since February.
New versions of the H5N1 virus are increasingly adept at spreading. Suggestions to either let it rip in poultry or vaccinate the birds could backfire.